Pricing Log in Create free account

Alector, Inc. (ALEC) vs Atea Pharmaceuticals, Inc. (AVIR)

Alector, Inc. and Atea Pharmaceuticals, Inc. are both Biotechnology companies. Alector, Inc. is the larger, with a market value of $376.7M against $336.9M — 1.1× the size. Atea Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Alector, Inc. trades at 7.1×. Alector, Inc. has the higher net margin (23.9% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Alector, Inc. leads on 8 and Atea Pharmaceuticals, Inc. on 6.

Valuation

Metric ALEC AVIR Biotechnology median
P/E 7.06 n/m 10.96
P/S 1.61 0.95 9.52
P/B 2.40 1.64 2.23
Price to free cash flow n/m n/m 25.69
EV/EBITDA 3.89 n/m 0.68
EV/Sales 0.92 0.33 9.00
Earnings yield 14.16% (49.64%) (32.09%)
Free cash flow yield (53.54%) (163.95%) (22.62%)

Profitability

Metric ALEC AVIR Biotechnology median
Gross margin 100.00% 0.00% 68.51%
Operating margin 20.16% 0.00% 0.00%
Net margin 23.87% 0.00% 0.00%
Free cash flow margin (86.31%) 0.00% 0.00%
Return on equity 47.52% (58.14%) (50.12%)
Return on assets 16.53% (52.99%) (45.12%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ALEC AVIR Biotechnology median
Revenue growth (TTM) 151.23% — 6.78%
EPS growth (last fiscal year) (13.01%) 3.00% 29.88%
Revenue growth, 5-year CAGR (0.05%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALEC AVIR Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.10 8.13 4.74
Net debt to EBITDA 1.61 1.63 1.01

Dividend

Metric ALEC AVIR Biotechnology median
Dividend yield — — 0.40%
Payout ratio — — —

Size

Metric ALEC AVIR Biotechnology median
Market cap 376.66m 336.86m 166.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack